Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Life and Health Insurance Industry Analysis

UpdatedSep 21, 2025
DataAggregated Company Financials
Companies1
  • 7D-0.6%
  • 3M3.1%
  • 1Y17.5%
  • YTDn/a

Over the last 7 days, the Life and Health Insurance industry has remained flat. The past year has been better, since the industry has gained 18% in that time. Looking forward, earnings are forecast to grow by 6.5% annually.

Industry Valuation and Performance

Has the Swiss Life and Health Insurance Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 21 Sep 2025CHF 23.4bCHF 11.6bCHF 1.2b19.9x19.9x2x
Tue, 19 Aug 2025CHF 25.7bCHF 12.0bCHF 1.2b21.2x21.2x2.1x
Thu, 17 Jul 2025CHF 23.4bCHF 12.0bCHF 1.2b19.2x19.2x1.9x
Sat, 14 Jun 2025CHF 22.8bCHF 12.0bCHF 1.2b18.8x18.8x1.9x
Mon, 12 May 2025CHF 24.0bCHF 12.0bCHF 1.2b19.8x19.8x2x
Wed, 09 Apr 2025CHF 21.0bCHF 12.0bCHF 1.2b17.3x17.3x1.8x
Fri, 07 Mar 2025CHF 22.0bCHF 11.5bCHF 1.1b20.4x20.4x1.9x
Sun, 02 Feb 2025CHF 20.9bCHF 11.5bCHF 1.1b19.3x19.3x1.8x
Tue, 31 Dec 2024CHF 19.6bCHF 11.5bCHF 1.1b18.1x18.1x1.7x
Thu, 28 Nov 2024CHF 20.1bCHF 11.5bCHF 1.1b18.6x18.6x1.7x
Sat, 26 Oct 2024CHF 19.9bCHF 11.5bCHF 1.1b18.4x18.4x1.7x
Mon, 23 Sep 2024CHF 19.7bCHF 11.5bCHF 1.1b18.2x18.2x1.7x
Wed, 21 Aug 2024CHF 18.9bCHF 11.1bCHF 1.1b17.4x17.4x1.7x
Fri, 19 Jul 2024CHF 18.8bCHF 11.1bCHF 1.1b17.4x17.4x1.7x
Sun, 16 Jun 2024CHF 18.2bCHF 11.1bCHF 1.1b16.8x16.8x1.6x
Tue, 14 May 2024CHF 18.7bCHF 11.1bCHF 1.1b17.3x17.3x1.7x
Thu, 11 Apr 2024CHF 18.0bCHF 11.1bCHF 1.1b16.6x16.6x1.6x
Sat, 09 Mar 2024CHF 18.4bCHF 21.8bCHF 1.4b13.5x13.5x0.8x
Mon, 05 Feb 2024CHF 17.5bCHF 21.8bCHF 1.4b12.8x12.8x0.8x
Wed, 03 Jan 2024CHF 16.5bCHF 21.8bCHF 1.4b12.1x12.1x0.8x
Fri, 01 Dec 2023CHF 15.8bCHF 21.8bCHF 1.4b11.6x11.6x0.7x
Sun, 29 Oct 2023CHF 16.1bCHF 21.8bCHF 1.4b11.8x11.8x0.7x
Tue, 26 Sep 2023CHF 16.2bCHF 21.8bCHF 1.4b11.8x11.8x0.7x
Thu, 24 Aug 2023CHF 15.3bCHF 21.2bCHF 1.4b10.5x10.5x0.7x
Sat, 22 Jul 2023CHF 15.4bCHF 21.2bCHF 1.4b10.6x10.6x0.7x
Mon, 19 Jun 2023CHF 15.9bCHF 21.2bCHF 1.4b11x11x0.8x
Wed, 17 May 2023CHF 15.7bCHF 21.2bCHF 1.4b10.8x10.8x0.7x
Fri, 14 Apr 2023CHF 17.5bCHF 21.2bCHF 1.4b12.1x12.1x0.8x
Sun, 12 Mar 2023CHF 17.8bCHF 22.3bCHF 1.3b14x14x0.8x
Tue, 07 Feb 2023CHF 16.8bCHF 22.3bCHF 1.3b13.2x13.2x0.8x
Thu, 05 Jan 2023CHF 15.3bCHF 22.3bCHF 1.3b12x12x0.7x
Sat, 03 Dec 2022CHF 15.7bCHF 22.3bCHF 1.3b12.4x12.4x0.7x
Mon, 31 Oct 2022CHF 14.7bCHF 22.3bCHF 1.3b11.6x11.6x0.7x
Wed, 28 Sep 2022CHF 13.5bCHF 22.3bCHF 1.3b10.6x10.6x0.6x
Price to Earnings Ratio

10.6x


Total Market Cap: CHF 13.5bTotal Earnings: CHF 1.3bTotal Revenue: CHF 22.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Life and Health Insurance Industry Price to Earnings3Y Average 15.2x202320242025
Current Industry PE
    There is only one company in the Swiss Life and Health Insurance industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life and Health Insurance industry have declined 2.4% per year over the last three years,
  • Revenues have also declined 19% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Comparison

How does Swiss Life and Health Insurance compare with similar industries?

CH Market-0.96%
Financials0.019%
Insurance-1.60%
Life and Health Insurance-0.65%
General Insurance-1.56%
Reinsurance-2.24%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News

SLHN
CHF 827.20
Swiss Life Holding
7D
-0.6%
1Y
17.5%

Self-funded Pensions And Digitalization Will Expand European Markets

Swiss Life Holding's consensus price target was modestly raised to CHF801.73, driven by improving earnings growth expectations, resilient fee and risk income, and strong cost discipline, despite some caution over macroeconomic headwinds following recent share price gains. Analyst Commentary Expectations of improved earnings growth supported modest price target increases.